22. RELATED PARTY TRANSACTIONS Parent entity Neuren Pharmaceuticals Limited is the ultimate parent entity (“Parent”). Subsidiaries Interests in subsidiaries are set out in Note 18. The Parent funds the activities of the subsidiaries throughout the year as needed. All amounts due between entities are payable on demand and bear no interest. Key management personnel Disclosures relating to key management personnel are set out in Note 21. Transactions with related parties There were no transactions with related parties during the current and previous financial year. Receivable from and payable to related parties There were no trade receivables from or trade payables to related parties at the current and previous reporting date. Loans to/from related parties There were no loans to or from related parties at the current and previous reporting date. 23. EVENTS AFTER THE REPORTING PERIOD No matter or circumstance has arisen since 31 December 2024 that has significantly affected, or may significantly affect the consolidated entity’s operations, the results of those operations, or the consolidated entity’s state of affairs in future financial years. NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS CONTINUED Neuren Pharmaceuticals Limited Annual Report 2024 47
RkJQdWJsaXNoZXIy MjE2NDg3